Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 1,856,628 |
|
|||||
| News | - | ||||||
| Day High | 2.35 | Low High |
|||||
| Day Low | 2.02 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Processa Pharmaceuticals Inc | PCSA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.33 | -13.58% | 2.10 | 18:54:30 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.19 | 2.02 | 2.35 | 2.15 | 2.43 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,143 | 1,856,628 | US$ 2.21 | US$ 4,096,053 | - | 1.40 - 18.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:58:16 | 33 | US$ 2.14 | USD |
Processa Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.61M | 1.23M | - | 0 | -11.12M | -9.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Processa Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PCSA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.53 | 2.68 | 1.50 | 2.43 | 15,439,005 | 0.57 | 37.25% |
| 1 Month | 2.38 | 3.305 | 1.40 | 2.42 | 4,496,782 | -0.28 | -11.76% |
| 3 Months | 2.42 | 3.305 | 1.40 | 2.42 | 1,569,123 | -0.32 | -13.22% |
| 6 Months | 6.818 | 17.40 | 1.40 | 4.70 | 2,178,638 | -4.72 | -69.20% |
| 1 Year | 10.702 | 18.00 | 1.40 | 6.56 | 1,602,761 | -8.60 | -80.38% |
| 3 Years | 178.80 | 184.80 | 1.40 | 11.13 | 582,919 | -176.70 | -98.83% |
| 5 Years | 76.00 | 284.798 | 1.40 | 14.36 | 501,584 | -73.90 | -97.24% |
Processa Pharmaceuticals Description
| Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100. |
